Perspectives and regulatory challenges for the application of stem cells in alternative methods to animal testing

Authors

  • Cintia Delai da Silva Horinouchi Laboratório de Biologia Básica de Células-Tronco, Instituto Carlos Chagas, Fiocruz-Paraná, Curitiba, PR Author
  • Ana Paula Ressetti Abud Laboratório de Biologia Básica de Células-Tronco, Instituto Carlos Chagas, Fiocruz-Paraná, Curitiba, PR Author
  • Ariane Caroline Paschoal Laboratório de Biologia Básica de Células-Tronco, Instituto Carlos Chagas, Fiocruz-Paraná, Curitiba, PR Author
  • Crisciele Kuligosvisk Laboratório de Biologia Básica de Células-Tronco, Instituto Carlos Chagas, Fiocruz-Paraná, Curitiba, PR Author
  • Thamile Luciane Reus Laboratório de Biologia Básica de Células-Tronco, Instituto Carlos Chagas, Fiocruz-Paraná, Curitiba, PR Author
  • Bruno Dallagiovanna Muniz Laboratório de Biologia Básica de Células-Tronco, Instituto Carlos Chagas, Fiocruz-Paraná, Curitiba, PR Author
  • Alessandra Melo de Aguiar Laboratório de Biologia Básica de Células-Tronco, Instituto Carlos Chagas, Fiocruz-Paraná, Curitiba, PR Author

DOI:

https://doi.org/10.22239/2317-269X.01076

Keywords:

Stem Cells, Biotechnology, Health Legislation, Regulation, Alternative Methods

Abstract

Introduction: The use of stem cells for toxicological evaluations seems to be a promising strategy since it allows a greater prediction of human effects. However, in Brazil, there is no specific legislation regulating the use of stem cells for non-therapeutic purposes, technological development, diagnosis or as an alternative method to animal testing. Objective: To review the literature and to provide an overview of the current situation of the non-therapeutic use of stem cells in Brazil and in the world. Method: A non-systematic bibliographic survey was carried out bringing together scientific articles and legislation. Results: This review brings the current approach of Brazilian legislation regarding the non-therapeutic use of human material and briefly discusses international regulatory approaches that allow the non-therapeutic use of stem cells. On the other hand, the Brazilian legislation for use of blood and blood products is quite broad and mature and could serve as a model for the non-therapeutic use of stem cells or other materials of human origin. Conclusions: The encouragement of the debate by the interested bodies and entities is the first step to initiate the development of specific legislation that could allow the scientific and technological development of Brazil in order to follow the world’s biotechnological advances.

Downloads

Download data is not yet available.

Published

2018-05-30

Issue

Section

Revision article

How to Cite

Perspectives and regulatory challenges for the application of stem cells in alternative methods to animal testing. (2018). Health Surveillance under Debate: Society, Science & Technology , 6(2), 92-105. https://doi.org/10.22239/2317-269X.01076